Anishiya Abrol

Hogan Lovells

+ Follow Contact

Latest Publications

Share:

Impacts of the U.S. IRA on licenses and collaborations

This is an article in our 2023 series, “Life Sciences Transactional Insights”, which aims to provide key practical takeaways for our transactional colleagues by anticipating the needs of their regulatory, intellectual...more

6/1/2023 / Drug Pricing , Health Care Providers , Inflation Reduction Act (IRA) , Life Sciences , Pharmaceutical Industry , Prescription Drugs

Spring cleaning: a transactional check-up for life sciences companies

Spring cleaning: a transactional check-up for life sciences companies - This is an article in our 2023 series, “Life Sciences Transactional Insights”, which aims to provide key practical takeaways for our transactional...more

4/4/2023 / Drug Pricing , Environmental Social & Governance (ESG) , Inflation Reduction Act (IRA) , Life Sciences , Patent Royalties , Pharmaceutical Industry , Unified Patent Court

CTGT transactions: Beware of ripples in the safe harbor

We increasingly encounter research and development collaboration partners relying on various research tools, cell lines, and other technologies to develop products and therapies within the cell, tissue, and gene therapy...more

6/10/2022 / Biologics , Food and Drug Administration (FDA) , Patent Infringement , Patents , Research and Development , Safe Harbors

3 Results

View per page

Page: of 1